Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AAPL vs GSK✓SelectedUSD · GSKAAPL vs GSK performance historyLatest closeAs of+0.15%11/18
Stock and ETF performance explorer

AAPL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,294.2%
GSK return
+101.2%
Excess return
+1,193.1%
Maximum drawdown
-38.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-1.3%+1.5%+0.6%
7D-0.8%-3.1%+2.3%+0.3%
30D+2.9%-0.9%+3.7%+3.1%
3M+13.8%-4.2%+17.9%+15.2%
6M+18.5%-1.6%+20.1%+18.7%
YTD+30.1%+2.6%+27.5%+27.8%
1Y+32.2%+6.2%+26.0%+28.2%
3Y+88.2%+55.0%+33.2%+53.0%
5Y+128.7%+42.8%+85.9%+88.9%
10Y+1,294.2%+102.1%+1,192.1%+885.8%
All+1,294.2%+101.2%+1,193.1%+885.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling